Effect of ω-3PUFA on Lipids and Expression of Inflammation in Type 2 Diabetes Mellitus

Xiao-bo GAO,Yong-xin JIN,Duo LI,Jing LI,Rui-hua GAO,Dan-dan LI,Wei-yu CHEN,Ling FANG
DOI: https://doi.org/10.3969/j.issn.1006-9577.2017.01.016
2017-01-01
Abstract:[Objective] To investigate the effect of ω-3 polyunsaturated fatty acid (ω-3PUFA) on lipidic and the expression of C-reactive protein and interleukin-6 in type 2 diabetes mellitus.[Method] Totally 108 patients with type 2 diabetes mellitus were randomely divided into three groups including A group (ω-3PUFA-DHA +EPA),B group (ω-3PUFA-ALA),C group (control),and gave them with different types of ω-3PUFA to test the changes of lipeds,C-reactive protein and interleukin-6 on 0,3 and 6 months.[Result] After treatment with n-3PUFA,high density lipoprotein of group A was increased in 3 months (P <0.05) and 6 months (P <0.01),total cholestrol was greatly decreased after 6 months (P < 0.05).The lipids between group B and group C had no difference between 3 and 6 months (P > 0.05).By comparing the C-reactive protein and interleukin-6 between group A and group C,it showed that ω-3PUFA (DHA + EPA) could inhibit the expression of C-reactive protein and interleukin-6 (P < 0.05).[Conclusion] n-3PUFA (DHA + EPA) could improve high density lipoprotein,lower total cholestrol,and inhibit the expression of C-reactive protein and interleukin-6.
What problem does this paper attempt to address?